Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ez-Tzu Wang"'
Autor:
Wei-Ju Su, Pei-Hung Chuang, Luan-Yin Chang, Hsiu-Yun Lo, Chuen-Sheue Chiang, Ez-Tzu Wang, Chin-Hui Yang
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background The Taiwanese national 23-valent pneumococcal polysaccharide vaccine (PPV23) program in adults ≥75 years of age and the 13-valent pneumococcal conjugate vaccine (PCV13) program for children were implemented in 2008 and 2013, res
Externí odkaz:
https://doaj.org/article/afd757aa58db4b81bd0c63018abeed38
Autor:
Su, Wei-Ju, Pei-Hung Chuang, Luan-Yin Chang, Hsiu-Yun Lo, Chuen-Sheue Chiang, Ez-Tzu Wang, Yang, Chin-Hui
Additional file 1: Supplementary Table 1. Serotype percentage of IPD in Taiwan from July 2008 to June 2016, stratified by age group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a6038f6e88bfca45f2014cb54781416
Autor:
Su, Wei-Ju, Pei-Hung Chuang, Luan-Yin Chang, Hsiu-Yun Lo, Chuen-Sheue Chiang, Ez-Tzu Wang, Yang, Chin-Hui
Additional file 3: Supplementary Table 3. Effectiveness of PPV23 in patients ≥75 years of age, estimated by the indirect cohort (Broome) method, July 2008 to June 2012 (n = 581).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6afb31e083274086f619505c018d9599
Autor:
Su, Wei-Ju, Pei-Hung Chuang, Luan-Yin Chang, Hsiu-Yun Lo, Chuen-Sheue Chiang, Ez-Tzu Wang, Yang, Chin-Hui
Additional file 2: Supplementary Table 2. Accumulated coverage of PPV23 in older adults, stratified by counties and age groups in Taiwan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e9a212537f369cce74cdf870350b06
Autor:
Chin-Hui Yang, Pei-Hung Chuang, Chuen-Sheue Chiang, Luan-Yin Chang, Wei-Ju Su, Ez-Tzu Wang, Hsiu-Yun Lo
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
Background The Taiwanese national 23-valent pneumococcal polysaccharide vaccine (PPV23) program in adults ≥75 years of age and the 13-valent pneumococcal conjugate vaccine (PCV13) program for children were implemented in 2008 and 2013, respectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d42ce27ffc19aba50c2883b6324dfb1
https://pubmed.ncbi.nlm.nih.gov/33423657
https://pubmed.ncbi.nlm.nih.gov/33423657